Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3300-3310

  Biniecka, Monika ^a   Connolly, Mary ^a   Gao, Wei ^a   Ng, Chin T ^b   Balogh, Emese ^a   Gogarty, Martina ^c   Santos, Lelani ^c   Murphy, Evelyn ^c   Brayden, David ^c   Veale, Douglas J ^a   Fearon, Ursula ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 2; BLOOD CLOTTING FACTOR 8; DIPHENYLIODONIUM SALT; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; VASCULOTROPIN; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; DBA MOUSE; ENDOTHELIUM CELL; EXPERIMENTAL ARTHRITIS; GENE EXPRESSION REGULATION; GENETICS; KNEE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANOXIA; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; KNEE JOINT; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84912052316     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38822     Document Type: Article

References (50)

1. Szekanecz Z, Besenyei T, Szentpetery A, Koch AE,. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2010; 22: 299-306.
2. Karouzakis E, Neidhart M, Gay RE, Gay S,. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006; 106: 8-13.
3. Szekanecz Z, Besenyei T, Paragh G, Koch AE,. Angiogenesis in rheumatoid arthritis. Autoimmunity 2009; 42: 563-73.
4. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, Wahlberg E,. Differential roles of PDGFR-α and PDGFR-β in angiogenesis and vessel stability. FASEB J 2009; 23: 153-63.
5. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003; 30: 260-8.
6. Hitchon CA, El-Gabalawy HS,. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6: 265-78.
7. Bir SC, Kolluru GK, Fang K, Kevil CG,. Redox balance dynamically regulates vascular growth and remodeling. Semin Cell Dev Biol 2012; 23: 745-57.
8. Taniyama Y, Griendling KK,. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42: 1075-81.
9. Konisti S, Kiriakidis S, Paleolog EM,. Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012; 8: 153-62.
10. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010; 62: 711-21.
11. Kennedy A, Ng CT, Chang TC, Biniecka M, O'Sullivan JN, Heffernan E, et al. Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. Arthritis Rheum 2011; 63: 923-32.
12. Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM,. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 2009; 11: R64.
13. Muz B, Khan MN, Kiriakidis S, Paleolog EM,. Hypoxia: the role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res Ther 2009; 11: 201.
14. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N,. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008; 33: 49-58.
15. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J,. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56.
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW,. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8.
17. Chenevier-Gobeaux C, Simonneau C, Lemarechal H, Bonnefont-Rousselot D, Poiraudeau S, Rannou F, et al. Hypoxia induces nitric oxide synthase in rheumatoid synoviocytes: consequences on NADPH oxidase regulation. Free Radic Res 2012; 46: 628-36.
18. Bayraktutan U, Blayney L, Shah AM,. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 1903-11.
19. Ray R, Shah AM,. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005; 109: 217-26.
20. Frey RS, Ushio-Fukai M, Malik AB,. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 2009; 11: 791-810.
21. Manea A,. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 2010; 342: 325-39.
22. Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, et al. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. PLoS One 2011; 6: e14665.
23. Phillips DC, Dias HK, Kitas GD, Griffiths HR,. Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal 2010; 12: 743-85.
24. Miesel R, Hartung R, Kroeger H,. Priming of NADPH oxidase by tumor necrosis factor α in patients with inflammatory and autoimmune rheumatic diseases. Inflammation 1996; 20: 427-38.
25. Chenevier-Gobeaux C, Lemarechal H, Bonnefont-Rousselot D, Poiraudeau S, Ekindjian OG, Borderie D,. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1β and tumour necrosis factor-α. Inflamm Res 2006; 55: 483-90.
26. Biniecka M, Kennedy A, Fearon U, Ng CT, Veale DJ, O'Sullivan JN,. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 2010; 69: 1172-8.
27. Ultaigh SN, Saber TP, McCormick J, Connolly M, Dellacasagrande J, Keogh B, et al. Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 2011; 13: R33.
28. Walsh CE, Ryan EJ, O'Farrelly C, Golden-Mason L, FitzGerald O, Veale DJ, et al. Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease. PLoS One 2011; 6: e27182.
29. Youssef PP, Kraan M, Breedveld F, Bresnihan B, Cassidy N, Cunnane G, et al. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis Rheum 1998; 41: 663-9.
30. Ng CT, Biniecka M, Kennedy A, McCormick J, FitzGerald O, Bresnihan B, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010; 69: 1389-95.
31. Oliver KM, Garvey JF, Ng CT, Veale DJ, Fearon U, Cummins EP, et al. Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal 2009; 11: 2057-64.
32. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
33. Fraser A, Fearon U, Reece R, Emery P, Veale DJ,. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001; 44: 2024-8.
34. Ospelt C, Neidhart M, Gay RE, Gay S,. Synovial activation in rheumatoid arthritis. Front Biosci 2004; 9: 2323-34.
35. Buckley CD, Rainger GE, Nash GB, Raza K,. Endothelial cells, fibroblasts and vasculitis. Rheumatology (Oxford) 2005; 44: 860-3.
36. Colville-Nash PR, Scott DL,. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 1992; 51: 919-25.
37. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002; 277: 3101-8.
38. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010; 467: 972-6.
39. phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 2005; 111: 2347-55.
40. Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, et al. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 2005; 167: 599-607.
41. Strehl C, Fangradt M, Fearon U, Gaber T, Buttgereit F, Veale DJ,. Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability? J Leukoc Biol 2014; 95: 233-41.
42. Del Rey MJ, Izquierdo E, Usategui A, Gonzalo E, Blanco FJ, Acquadro F, et al. The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia. Arthritis Rheum 2010; 62: 3584-94.
43. Brouwer E, Gouw AS, Posthumus MD, van Leeuwen MA, Boerboom AL, Bijzet J, et al. Hypoxia inducible factor-1-α (HIF-1α) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 945-51.
44. Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, et al. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011; 13: R121.
45. Diebold I, Petry A, Sabrane K, Djordjevic T, Hess J, Gorlach A,. The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J Cell Sci 2012; 125: 956-64.
46. Shono T, Ono M, Izumi H, Jimi SI, Matsushima K, Okamoto T, et al. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996; 16: 4231-9.
47. Yun MR, Park HM, Seo KW, Lee SJ, Im DS, Kim CD,. 5-lipoxygenase plays an essential role in 4-HNE-enhanced ROS production in murine macrophages via activation of NADPH oxidase. Free Radic Res 2010; 44: 742-50.
48. Vladykovskaya E, Sithu SD, Haberzettl P, Wickramasinghe NS, Merchant ML, Hill BG, et al. Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress. J Biol Chem 2012; 287: 11398-409.
49. Vatsyayan R, Lelsani PC, Chaudhary P, Kumar S, Awasthi S, Awasthi YC,. The expression and function of vascular endothelial growth factor in retinal pigment epithelial (RPE) cells is regulated by 4-hydroxynonenal (HNE) and glutathione S-transferaseA4-4. Biochem Biophys Res Commun 2012; 417: 346-51.
50. Lamalice L, Le Boeuf F, Huot J,. Endothelial cell migration during angiogenesis. Circ Res 2007; 100: 782-94.